Edit
STA Pharmaceutical, a WuXi AppTec Company (WuXi STA)
http://www.stapharma.com/Last activity: 26.09.2022
WuXi STA, a WuXi AppTec company, is a leading pharmaceutical development and manufacturing capability and technology platform company serving the life science industry, with 14 sites across Asia, North America, and Europe.
As a premier Contract Research, Development, and Manufacturing Organization (CRDMO), WuXi STA offers our worldwide partners efficient, flexible and high-quality solutions for small molecule Active Pharmaceutical Ingredients (APIs) and finished dosage forms. Our globally integrated CMC platform supports small molecules, oligonucleotides, peptides and antibody drug conjugates from preclinical to commercial.
Visit WuXi STA website: https://stapharma.com
Visit Peptide CRDMO website: https://peptide.wuxiapptec.com
Location: China, Shanghai
Employees: 5001-10000
Founded date: 2000
Investors 1
Date | Name | Website |
- | Terra Magn... | terramagnu... |
Mentions in press and media 11
Date | Title | Description | Source |
26.09.2022 | WuXi STA Opens First High Potency Oral Drug Product Manufact... | New facility expands integrated drug product R&D and manufacturing services to global customers ... | en.prnasia... |
09.09.2022 | WuXi STA Opens a New Sterile Lipid Nanoparticle Formulation ... | SHANGHAI, Sept. 9, 2022 /PRNewswire/ -- WuXi STA, a subsidiary of WuXi AppTec, today announced the o... | en.prnasia... |
17.08.2022 | WuXi STA Breaks Ground for New Pharmaceutical Manufacturing ... | MIDDLETOWN, Del., Aug. 17, 2022 /PRNewswire/ -- WuXi STA, a leading Contract Research, Development, ... | en.prnasia... |
07.07.2022 | Manufacturing roundup: WuXi continues its expansion ... | Spurred on by a growing demand for outsourced manufacturing, a slew of CDMO firms have uncorked big ... | endpts.com... |
07.07.2022 | WuXi STA Opens New Large-scale Oligonucleotide and Peptide M... | Site Enhances New Modality CRDMO Platform Capacity for Customers SHANGHAI, July 7, 2022 /PRNewswire/... | en.prnasia... |
11.02.2022 | WuXi STA Wins 2022 CMO Leadership Awards in All Six Core Cat... | SHANGHAI, Feb. 11, 2022 /PRNewswire/ -- WuXi STA, a subsidiary of WuXi AppTec, today announced that ... | en.prnasia... |
01.07.2021 | New to the party, Novartis seeks to plunge into mRNA... | It’s increasingly unclear just how long Biogen will have the only major Alzheimer’s drug on the mark... | endpts.com... |
01.07.2021 | Horizon takes the leap into manufacturing, buying out... | Horizon Therapeutics, the biotech known for scooping up orphan drugs, has made its first fora... | endpts.com... |
01.07.2021 | New to the party, Novartis seeks to plunge into mRNA... | After fighting a years-long uphill battle with its oral microbiome candidate SER-109, Seres Therapeu... | endpts.com... |
14.05.2021 | WuXi Biologics and WuXi STA Jointly Established WuXi XDC to ... | WUXI, China, May 14, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global ... | en.prnasia... |
Show more